(2S,4AS,5AS)-6A-HYDROXY-2-(3-HYDROXYADAMANTAN-1-YL)HEXAHYDROCYCLOPROPA(4,5)PYRROLO(1,2-A)IMIDAZOL-3(2H)-ONE
UNII NHA7BVE9GU
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s,4as,5as)-6a-hydroxy-2-(3-hydroxyadamantan-1-yl)hexahydrocyclopropa(4,5)pyrrolo(1,2-a)imidazol-3(2h)-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NHA7BVE9GU.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H24N2O3 FRYSGXJFJVWGRL-GTFNWJGBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s,4as,5as)-6a-hydroxy-2-(3-hydroxyadamantan-1-yl)hexahydrocyclopropa(4,5)pyrrolo(1,2-a)imidazol-3(2h)-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.